Skip directly to site content
Are You Still There?
Due to inactivity, you will be signed out in two minutes unless you click 'Continue'.

Are you still there?

Due to inactivity, you will be signed out in two minutes unless
you click 'Continue'.

Panel: 
AR Bank #

Biosample Accession #:

   


Panel:    |  Isolates with New or Novel Antibiotic Resistance (NEW)


MIC (μg/ml) Results and Interpretation
Drug MIC (μg/ml) INT
MICs obtained by broth microdilution. Modal MIC is reported
S – I –R Interpretation (INT) derived from CLSI 2025 M100 S35
Device manufacturers and users of FDA cleared devices shall consult the FDA’s Antibacterial Susceptibility Test Interpretive Criteria       website for breakpoints recognized or recommended by FDA, and for information regarding FDA exceptions or additions to the applicable, recognized consensus standard.
Molecular Mechanisms of Resistance
CategoryGene
No data available
 
Disclaimer:
Propagation
MEDIUM
Medium: Label

GROWTH CONDITIONS
Temperature: Label°C
Atmosphere: Label

PROPAGATION PROCEDURE
Label
Storage Temperature & Biosafety
STORAGE TEMPERATURE: °C

BIOSAFETY LEVEL:


Disclaimer:
Isolate History
Date Action Performed
03/13/23INT was updated with a new value for Minocycline: from '---' to 'I'
03/13/23MIC was updated with a new value for Minocycline: from '---' to '8'
03/13/23Drug was added: Minocycline
03/13/23INT was updated with a new value for Meropenem-vaborbactam: from '---' to 'S'
03/13/23MIC was updated with a new value for Meropenem-vaborbactam: from '---' to '<=0.5'
03/13/23Drug was added: Meropenem-vaborbactam
03/13/23INT was updated with a new value for Imipenem/relebactam: from '---' to 'S'
03/13/23MIC was updated with a new value for Imipenem/relebactam: from '---' to '<=0.25'
03/13/23Drug was added: Imipenem/relebactam
Top of Page
TOP